We are live on
!
Find out more
FCM
Farallon Capital Management Portfolio holdings
AUM
$17.5B
1-Year Est. Return
50.95%
This Fund
S&P 500
This Quarter
Est. Return
+19.41%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$16.6B
AUM Growth
+$2.17B
(+15%)
Cap. Flow
-$81M
Cap. Flow
% of AUM
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
31.47%
Holding
166
New
39
Increased
28
Reduced
33
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aramark
ARMK
|
+$366M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$332M |
| 3 |
RTX Corp
RTX
|
+$299M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$289M |
| 5 |
Broadcom
AVGO
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$498M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$299M |
| 3 |
AbbVie
ABBV
|
+$298M |
| 4 |
Palo Alto Networks
PANW
|
+$217M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.27% |
| 2 | Communication Services | 13.23% |
| 3 | Financials | 10.05% |
| 4 | Technology | 9.85% |
| 5 | Industrials | 8.49% |
Similar funds
BBA
MCM
LA
CM
ASRS
PP
VMPIC
HNB
Farallon Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Farallon Capital Management held 166 positions worth $16.6B, up 15% from $14.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Farallon Capital Management's Q4 2020 filing shows 39 new, 28 increased, 33 reduced and 30 closed positions. Its largest new stake was Aramark: 15,268,169 shares worth $424M. The largest sale was Immunomedics Inc, an estimated $498M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Communication Services and Financials.
- Farallon Capital Management's largest Q4 2020 buy was Aramark: 15,268,169 shares worth $424M.
- Farallon Capital Management added most to Willis Towers Watson in Q4 2020, an estimated $188M increase.
- Farallon Capital Management's biggest Q4 2020 reduction was AbbVie, cutting an estimated $298M.
- Farallon Capital Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $498M.
- Farallon Capital Management's ten largest holdings make up 31% of its $16.6B portfolio in Q4 2020.
- Farallon Capital Management opened 39 new positions and closed 30 in Q4 2020.
- Farallon Capital Management's portfolio value rose 15% quarter-over-quarter to $16.6B.
Based on Farallon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.